MedTrace Logo

Impaired Peripheral Endothelial Function and In-stent Restenosis

NCT02131935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 513

Last updated 2014-05-28

No results posted yet for this study

Summary

The investigators assessed the hypothesis that whether RH-PAT index (RHI) as a marker of endothelial dysfunction could predict occurrence of ISR after percutaneous coronary intervention (PCI).

Conditions

Sponsors & Collaborators

  • Kumamoto University

    lead OTHER

Principal Investigators

  • Hisao Ogawa, MD, PhD · Kumamoto University

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-09-30
Completion
2014-05-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02131935 on ClinicalTrials.gov